Creative Medical Technology (CELZ) Competitors $3.47 +0.06 (+1.76%) As of 10/14/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. ITRM, MAAQ, PLUR, RANI, QTTB, TENX, PYRGF, SCYX, SONN, and AKTXShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Iterum Therapeutics (ITRM), Mana Capital Acquisition (MAAQ), Pluri (PLUR), Rani Therapeutics (RANI), Q32 Bio (QTTB), Tenax Therapeutics (TENX), PyroGenesis Canada (PYRGF), SCYNEXIS (SCYX), Sonnet BioTherapeutics (SONN), and Akari Therapeutics (AKTX). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Iterum Therapeutics Mana Capital Acquisition Pluri Rani Therapeutics Q32 Bio Tenax Therapeutics PyroGenesis Canada SCYNEXIS Sonnet BioTherapeutics Akari Therapeutics Creative Medical Technology (NASDAQ:CELZ) and Iterum Therapeutics (NASDAQ:ITRM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability. Which has preferable valuation and earnings, CELZ or ITRM? Creative Medical Technology has higher revenue and earnings than Iterum Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Iterum Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K895.26-$5.49M-$3.18-1.09Iterum TherapeuticsN/AN/A-$24.77M-$0.85-0.86 Do analysts recommend CELZ or ITRM? Iterum Therapeutics has a consensus target price of $9.00, indicating a potential upside of 1,132.88%. Given Iterum Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Iterum Therapeutics is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Iterum Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals believe in CELZ or ITRM? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 9.2% of Iterum Therapeutics shares are held by institutional investors. 1.8% of Creative Medical Technology shares are held by insiders. Comparatively, 2.4% of Iterum Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer CELZ or ITRM? In the previous week, Iterum Therapeutics had 2 more articles in the media than Creative Medical Technology. MarketBeat recorded 4 mentions for Iterum Therapeutics and 2 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 1.20 beat Iterum Therapeutics' score of 0.47 indicating that Creative Medical Technology is being referred to more favorably in the media. Company Overall Sentiment Creative Medical Technology Positive Iterum Therapeutics Neutral Is CELZ or ITRM more profitable? Iterum Therapeutics' return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -82.99% -79.49% Iterum Therapeutics N/A N/A -65.01% Which has more risk & volatility, CELZ or ITRM? Creative Medical Technology has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500. Comparatively, Iterum Therapeutics has a beta of 3.24, meaning that its share price is 224% more volatile than the S&P 500. SummaryIterum Therapeutics beats Creative Medical Technology on 11 of the 14 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.80M$3.35B$6.04B$10.51BDividend YieldN/A2.30%5.73%4.80%P/E Ratio-1.0921.9084.7027.24Price / Sales895.26266.35514.31200.41Price / CashN/A46.9537.5761.53Price / Book0.9610.4312.316.74Net Income-$5.49M-$52.58M$3.32B$276.59M7 Day Performance-2.80%-1.55%-1.33%-0.47%1 Month Performance-0.29%12.96%8.13%7.47%1 Year Performance-35.14%15.43%73.08%34.58% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology1.4202 of 5 stars$3.47+1.8%N/A-23.6%$8.80M$10K-1.095Positive NewsAnalyst ForecastITRMIterum Therapeutics1.8849 of 5 stars$0.77+0.9%$9.00+1,073.4%-27.7%$35.90MN/A-0.9010News CoverageMAAQMana Capital AcquisitionN/A$4.40-3.4%N/A-26.0%$35.71MN/A0.001PLURPluri2.1406 of 5 stars$4.38+1.7%$12.00+174.3%-9.4%$35.70M$1.34M-0.85150RANIRani Therapeutics3.3442 of 5 stars$0.49-1.3%$7.33+1,387.5%-84.8%$35.50M$1.03M-0.54110QTTBQ32 Bio2.9611 of 5 stars$2.90+15.0%$12.17+319.8%-91.6%$35.36M$1.16M-0.6739Analyst ForecastTENXTenax Therapeutics2.6232 of 5 stars$7.54+0.7%$18.00+138.7%+98.2%$34.45MN/A-8.219Analyst ForecastPYRGFPyroGenesis Canada0.0698 of 5 stars$0.18-2.0%N/A-68.1%$34.36M$9.14M-3.0590High Trading VolumeSCYXSCYNEXIS0.8414 of 5 stars$0.81+1.7%N/A-46.9%$33.79M$3.75M-2.0160Analyst ForecastSONNSonnet BioTherapeutics2.1253 of 5 stars$4.94-2.3%$20.00+305.2%-6.9%$33.74M$20K0.0010Gap DownAKTXAkari Therapeutics2.8272 of 5 stars$1.03-1.9%$3.30+220.4%-63.0%$33.60MN/A0.009 Related Companies and Tools Related Companies Iterum Therapeutics Alternatives Mana Capital Acquisition Alternatives Pluri Alternatives Rani Therapeutics Alternatives Q32 Bio Alternatives Tenax Therapeutics Alternatives PyroGenesis Canada Alternatives SCYNEXIS Alternatives Sonnet BioTherapeutics Alternatives Akari Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
